Cornerstone Advisory, LLC Pfizer Inc Transaction History

Cornerstone Advisory, LLC

$848 Million
Q2 2025

A detailed history of Cornerstone Advisory, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cornerstone Advisory, LLC holds 13,157 shares of PFE stock, worth $318,794. This represents 0.04% of its overall portfolio holdings.

Number of Shares

13,157

Previous 10,316 27.54%

Holding current value

$318,794

Previous $261,000 21.84%

% of portfolio

0.04%

Previous 0.03%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	BUY	$21.59 - $24.84 $61,337 - $70,570	2,841 Added 27.54%	13,157 $318,000
Q1 2025 May 07, 2025	SELL	$25.01 - $27.13 $68,127 - $73,902	-2,724 Reduced 20.89%	10,316 $261,000
Q4 2024 Feb 18, 2025	SELL	$24.8 - $30.19 $92,975 - $113,182	-3,749 Reduced 22.33%	13,040 $345,000
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $11,440 - $12,964	-413 Reduced 2.4%	16,789 $485,000
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $190,485 - $223,213	-7,541 Reduced 30.48%	17,202 $481,000
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $113,631 - $130,484	-4,389 Reduced 15.07%	24,743 $686,000
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $1,175 - $1,527	45 Added 0.15%	29,132 $838,000
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $90,301 - $105,553	-2,814 Reduced 8.82%	29,087 $964,000
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $144,877 - $167,619	-4,011 Reduced 11.17%	31,901 $1.17 Million
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $34,348 - $44,716	-872 Reduced 2.37%	35,912 $1.47 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $90,681 - $118,374	2,172 Added 6.28%	36,784 $1.89 Million
Q3 2022 Oct 26, 2022	BUY	$43.76 - $53.42 $80,780 - $98,613	1,846 Added 5.63%	34,612 $1.52 Million
Q2 2022 Aug 02, 2022	SELL	$46.53 - $55.17 $1.01 Million - $1.2 Million	-21,738 Reduced 39.88%	32,766 $1.72 Million
Q1 2022 May 20, 2022	SELL	$45.75 - $56.69 $5,718 - $7,086	-125 Reduced 0.23%	54,504 $2.82 Million
Q4 2021 Feb 23, 2022	SELL	$41.32 - $61.25 $69,541 - $103,083	-1,683 Reduced 2.99%	54,629 $3.23 Million
Q3 2021 Nov 16, 2021	BUY	$39.25 - $50.42 $80,227 - $103,058	2,044 Added 3.77%	56,312 $2.42 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $345,526 - $391,422	9,622 Added 21.55%	54,268 $2.13 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $146,887 - $165,659	4,386 Added 10.89%	44,646 $1.62 Million
Q4 2020 May 11, 2021	BUY	$33.47 - $42.56 $174,880 - $222,376	5,225 Added 14.91%	40,260 $1.48 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $644,715 - $756,398	20,306 Added 137.86%	35,035 $1.29 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $1,626 - $1,973	-54 Reduced 0.37%	14,729 $482,000
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $113,634 - $162,358	-4,204 Reduced 22.14%	14,783 $483,000
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $142,543 - $161,768	4,330 Added 29.54%	18,987 $744,000
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $32 - $42	1 Added 0.01%	14,657 $527,000
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $3,069 - $3,446	-83 Reduced 0.56%	14,656 $635,000
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $26,887 - $29,540	717 Added 5.11%	14,739 $626,000
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $60,474 - $68,947	1,572 Added 12.63%	14,022 $612,000
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $47,706 - $57,865	-1,384 Reduced 10.0%	12,450 $549,000
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $54,566 - $63,304	-1,710 Reduced 11.0%	13,834 $491,000
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $46,031 - $48,841	1,384 Added 9.77%	15,544 $563,000
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $32,054 - $35,311	-1,034 Reduced 6.81%	14,160 $506,000
Q2 2017 Aug 08, 2017	BUY	N/A	15,194	15,194 $510,000

Others Institutions Holding PFE

# of Institutions

3,290

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $136B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisory, LLC with notifications on news.

Account

Cornerstone Advisory, LLC Pfizer Inc Transaction History